Researchers conducted a retrospective cohort study to assess the predictive value of molecular profiling on thyroid tumor behavior.

Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe ...

Levels of kidney injuring molecule–1 appear to be predictive of therapeutic benefit in patients with renal cell carcinoma.